BR112012006056A2 - forma de dosagem - Google Patents
forma de dosagemInfo
- Publication number
- BR112012006056A2 BR112012006056A2 BR112012006056A BR112012006056A BR112012006056A2 BR 112012006056 A2 BR112012006056 A2 BR 112012006056A2 BR 112012006056 A BR112012006056 A BR 112012006056A BR 112012006056 A BR112012006056 A BR 112012006056A BR 112012006056 A2 BR112012006056 A2 BR 112012006056A2
- Authority
- BR
- Brazil
- Prior art keywords
- dosage form
- water solubility
- low water
- polymeric matrix
- hydrophilic polymer
- Prior art date
Links
- 239000002552 dosage form Substances 0.000 title abstract 3
- 239000013543 active substance Substances 0.000 abstract 2
- 239000011159 matrix material Substances 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- 239000004721 Polyphenylene oxide Substances 0.000 abstract 1
- 229920001477 hydrophilic polymer Polymers 0.000 abstract 1
- 229920000570 polyether Polymers 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
forma de dosagem. a invenção diz respeito a formas de dosagem que contêm preparações de substâncias ativas com uma baixa solubilidade em água em uma matriz polimétrica compreendendo copolímeros de poliéter anfifílicos e pelo menos um polímero hidrofílico, a substância ativa tendo um abaixa solubilidade em água estando presente na matriz polimérica em uma forma amorfa.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09170702 | 2009-09-18 | ||
PCT/EP2010/063735 WO2011033085A1 (de) | 2009-09-18 | 2010-09-17 | Schnell lösliche feste pharmazeutische zubereitungen enthaltend amphiphile copolymere auf basis von polyethern in kombination mit hydrophilen polymeren |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112012006056A2 true BR112012006056A2 (pt) | 2016-03-29 |
Family
ID=43017117
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012006056A BR112012006056A2 (pt) | 2009-09-18 | 2010-09-17 | forma de dosagem |
Country Status (6)
Country | Link |
---|---|
US (1) | US20120202894A1 (pt) |
EP (1) | EP2477606A1 (pt) |
JP (1) | JP2013505222A (pt) |
CN (1) | CN102655857A (pt) |
BR (1) | BR112012006056A2 (pt) |
WO (1) | WO2011033085A1 (pt) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9032390B2 (en) * | 2008-07-29 | 2015-05-12 | Qualcomm Incorporated | Framework versioning |
US8636929B2 (en) | 2010-05-21 | 2014-01-28 | Basf Se | Nanoporous foamed active compound-containing preparations based on pharmaceutically acceptable thermoplastically workable polymers |
US8715729B2 (en) | 2010-12-22 | 2014-05-06 | Basf Se | Rapidly disintegrating, solid coated dosage form |
US20160000720A1 (en) * | 2013-02-14 | 2016-01-07 | Aurobindo Pharma Limited | Pharmaceutical compositions comprising Tadalafil |
US20160193151A1 (en) * | 2015-01-06 | 2016-07-07 | Maria Del Pilar Noriega Escobar | Dosage form incorporating an amorphous drug solid solution |
WO2017067841A1 (de) * | 2015-10-23 | 2017-04-27 | Basf Se | Feste lösungen von geruchs- und geschmacksstoffen mit vinyllactampolymeren |
EP3668505A4 (en) | 2017-08-15 | 2021-05-12 | Nephron Pharmaceuticals Corporation | Aqueous fogging composition |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050181055A1 (en) * | 2003-10-08 | 2005-08-18 | Mathur Rajeev S. | Pharmaceutical compositions of quinapril |
EP1701703B1 (en) * | 2003-12-31 | 2011-03-09 | Bend Research, Inc. | Stabilized pharmaceutical solid compositions of low-solubility drugs, poloxamers and stabilizing polymers |
DE102005026755A1 (de) * | 2005-06-09 | 2006-12-14 | Basf Ag | Herstellung von festen Lösungen schwerlöslicher Wirkstoffe durch Kurzzeitüberhitzung und schnelle Trocknung |
DE102005053066A1 (de) * | 2005-11-04 | 2007-05-10 | Basf Ag | Verwendung von Copolymeren als Solubilisatoren für in Wasser schwerlöslichen Verbindungen |
US20070141148A1 (en) * | 2005-11-30 | 2007-06-21 | Merz Pharma Gmbh & Co. Kgaa | Neramexane MR matrix tablet |
WO2009013202A1 (de) * | 2007-07-26 | 2009-01-29 | Basf Se | Verfahren zur herstellung von durch pfropfpolymerisation in lösung erhaltenen copolymeren auf basis von polyethern in fester form |
EP2344138B1 (de) | 2008-09-25 | 2014-07-16 | Basf Se | Verwendung von copolymeren auf basis von polyethern und vinylmonomeren als bindemittel für feste wirkstoffhaltige dosierungsformen |
WO2010112489A2 (de) * | 2009-03-31 | 2010-10-07 | Basf Se | Verfahren zur herstellung von zubereitungen von in wasser schwerlöslichen substanzen |
WO2010130728A2 (de) | 2009-05-13 | 2010-11-18 | Basf Se | Feste pharmazeutischen zubereitungen enthaltend copolymere auf basis von polyethern in kombination mit wasserschwerlöslichen polymeren |
-
2010
- 2010-09-17 JP JP2012529292A patent/JP2013505222A/ja not_active Withdrawn
- 2010-09-17 CN CN2010800436716A patent/CN102655857A/zh active Pending
- 2010-09-17 BR BR112012006056A patent/BR112012006056A2/pt not_active IP Right Cessation
- 2010-09-17 US US13/496,656 patent/US20120202894A1/en not_active Abandoned
- 2010-09-17 WO PCT/EP2010/063735 patent/WO2011033085A1/de active Application Filing
- 2010-09-17 EP EP10754933A patent/EP2477606A1/de not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
CN102655857A (zh) | 2012-09-05 |
US20120202894A1 (en) | 2012-08-09 |
JP2013505222A (ja) | 2013-02-14 |
EP2477606A1 (de) | 2012-07-25 |
WO2011033085A1 (de) | 2011-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012006056A2 (pt) | forma de dosagem | |
BR112015021002A2 (pt) | forma de dosagem sólida restringente de abuso para liberação imediata com entalhe funcional | |
GT200600097A (es) | Formas farmaceuticas con propiedades farmacocineticas mejoradas | |
DE602007012354D1 (de) | Medizinisches abgabeystem mit drehbarem verschlüsselungselement | |
EA200802184A1 (ru) | Фармацевтические композиции с ингибиторами dpp iv | |
AR072761A1 (es) | Mezcla de fibras pediatrica | |
CL2012001103A1 (es) | Método para reducir el nivel del polipéptido tau desacetilado en una célula, que comprende poner en contacto la célula con un agente que incrementa la actividad de un polipéptido que desacetila tau y/o un agente que disminuye la actividad de un polipéptido que acetila tau; y usos terapéuticos para tratar una tauopatía. | |
CL2007003199A1 (es) | Receptaculo con un ingrediente activo que comprende un cuerpo adaptado conteniendo un primer ingrediente activo y un par de filtros espaciados adaptados para retener el ingrediente activo dentro del receptaculo, permitiendo al mismo tiempo el paso de | |
EA201200484A1 (ru) | Фармацевтическая композиция с действующими веществами - метформином и ситаглиптином или вилдаглиптином | |
HRP20191489T1 (hr) | Kombinirani sastav | |
BRPI0817974A2 (pt) | Combinações de substâncias ativas com propriedades inseticidas e acaricidas. | |
AR084567A1 (es) | Implante con calcio en su superficie y metodos de modificacion de la superficie de un implante para dotar a dicha superficie de calcio | |
CR11744A (es) | Formulacion liquida para deferiprona con gusto agradable al paladar | |
BR112015000244A2 (pt) | membranas termoplásticas incluindo polímero com funcionalidade reativa a isocianato | |
CL2012002781A1 (es) | Producto que comprende un cuerpo de alimento compuesto por un componente de alimento y un componente de infusion que contiene mal todextrina en una concentracon de 5 a 65% con respecto al cuerpo del alimento; producto alimenticio; metodo para producir un cuerpo de alimento infusionado; y formulaciones de infusion. | |
BRPI0800377A (pt) | bastão de tinta de travamento de múltiplas posições | |
BRPI0924986A2 (pt) | "combinações de substâncias ativas com propriedades inseticidas e acaricidas". | |
AR064104A1 (es) | Formas de dosificacion en microemulsion de valsartan, y metodos para elaborarlas | |
BRPI0921011A2 (pt) | métodos para provocar pelo menos um de um aumento no umedecimento oral e alívio de um sintoma associado com a hipossalivação , e aumento nos níveis de umedecimento oral, e, produto para cuidado oral | |
PA8824601A1 (es) | Utilizacion de dronedarona para preparar un medicamento para el tratamiento de pacientes con arritmia | |
BRPI0914808A2 (pt) | composição contendo polímero e copolimero metacrílico tendo grupos associados | |
CL2010001594A1 (es) | Uso de nifurtimox para preparar un medicamento útil en el tratamiento de enfermedades causadas por trichomonadida. | |
ATE480282T1 (de) | Spritzenzylinder | |
BR112012018509A2 (pt) | gel biologicamente compatível, método de preparo do gel e uso de gel biologicamente compatível | |
BRPI0910559A2 (pt) | associação da dronedarona com pelo menos um diurético, e sua aplicação em terapêutica. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A E 6A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2383 DE 06-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |